Bad blood, bad endothelium: Ill fate?

Blood

Volumn 117, Issue 13, 2011, Pages 3479-3480

  Yoder, Mervin ^a   Rounds, Sharon ^a  

^a BROWN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD133 ANTIGEN; CD34 ANTIGEN; SCATTER FACTOR; STAT3 PROTEIN; STAT5 PROTEIN; STROMAL CELL DERIVED FACTOR 1ALPHA;

BLOOD; BONE MARROW; CELL PROLIFERATION; ENDOTHELIUM; GENE MUTATION; HEMANGIOBLAST; HUMAN; LUNG TRANSPLANTATION; MYELOFIBROSIS; MYELOPROLIFERATIVE DISORDER; NOTE; PRIORITY JOURNAL; PULMONARY HYPERTENSION; SIGNAL TRANSDUCTION; STEM CELL;

EID: 79953673558     PISSN: 00064971     EISSN: 15280020     Source Type: Journal    
DOI: 10.1182/blood-2011-02-332643     Document Type: Note

References (8)

1. Farha S, Asosingh K, Xu W, et al. Hypoxia-inducible factors in human pulmonary arterial hypertension: a link to the intrinsic myeloid abnormalities. Blood. 2011;117(13):3485-3493.
2. Simonneau G, Robbins IM, Beghetti M, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol. 2009;54(1 suppl):S43-S54.
3. Rai PR, Cool CD, King JA, et al. The cancer paradigm of severe pulmonary arterial hypertension. Am J Respir Crit Care Med. 2008;178(6):558-564.
4. Erzurum S, Rounds SI, Stevens T, et al. Strategic plan for lung vascular research: An NHLBI-ORDR Workshop Report.AmJ Respir Crit Care Med. 2010;182(12):1554-1562.
5. Hirschi KK, Ingram DA, Yoder MC. Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol. 2008;28(9):1584-1595.
6. Asosingh K, Aldred MA, Vasanji A, et al. Circulating angiogenic precursors in idiopathic pulmonary arterial hypertension. Am J Pathol. 2008;172(3):615-627. (Pubitemid 351354535)
7. Popat U, Frost A, Liu E, et al. High levels of circulating CD34 cells, dacrocytes, clonal hematopoiesis, and JAK2 mutation differentiate myelofibrosis with myeloid metaplasia from secondary myelofibrosis associated with pulmonary hypertension. Blood. 2006;107(9):3486-3488.
8. Humbert M, Sitbon O, Chaouat A, et al. Survival in patients with idiopathic, familial, and anorexigen-associated pulmonary arterial hypertension in the modern management era. Circulation. 2010;122(2):156-163.